Lantern Pharma Inc.: 10-Q filed 2020-10-29
What Lantern Pharma Inc. reported in its quarterly report filed 2020-10-29 (fiscal Q3 2020): 22 published measures, 62 facts as tagged in accession 0001213900-20-033954.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-10-29
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001213900-20-033954 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lantern Pharma Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 22,492,952 | USD | |
| At 2019-12-31 | 1,432,576 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 923,057 | USD | |
| At 2019-12-31 | 489,292 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 21,569,895 | USD | |
| At 2020-06-30 | 23,227,869 | USD | |
| At 2020-03-31 | 536,468 | USD | |
| At 2019-12-31 | 943,284 | USD | |
| At 2019-09-30 | 1,555,047 | USD | |
| At 2019-06-30 | 1,121,396 | USD | |
| At 2019-03-31 | 1,744,760 | USD | |
| At 2018-12-31 | -201,798 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 20,802,542 | USD | |
| At 2019-12-31 | 1,232,030 | USD | |
| At 2019-09-30 | 1,940,906 | USD | |
| At 2018-12-31 | 445,163 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -1,701,488 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -3,012,186 | USD | 274 |
| 2019-07-01 to 2019-09-30 | -669,652 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -1,753,018 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -4,083,564 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -1,419,047 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 23,665,221 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 2,920,507 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -11,145 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -5,717 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | -9,763,891 | USD | |
| At 2019-12-31 | -6,751,705 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 17,608 | USD | |
| At 2019-12-31 | 8,758 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 43,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 167,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 32,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 54,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 22,475,344 | USD | |
| At 2019-12-31 | 1,232,818 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 814,557 | USD | |
| At 2019-12-31 | 489,292 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,701,488 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 3,012,186 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 669,652 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,753,018 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 21,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 6,217,577 | shares | |
| At 2019-12-31 | 1,978,269 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 31,333,164 | USD | |
| At 2019-12-31 | 7,694,547 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,672,802 | USD | |
| At 2019-12-31 | 788 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -1,701,488 | USD | 92 |
| 2020-04-01 to 2020-06-30 | -833,422 | USD | 91 |
| 2020-01-01 to 2020-03-31 | -477,276 | USD | 91 |
| 2019-07-01 to 2019-09-30 | -669,652 | USD | 92 |
| 2019-04-01 to 2019-06-30 | -629,393 | USD | 91 |
| 2019-01-01 to 2019-03-31 | -453,973 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,100,719 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 2,117,290 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 441,251 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 977,300 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 2,295 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 1,091 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -169,049 | USD | 274 |
Inspect the source
- Entity
- Lantern Pharma Inc. / CIK 0001763950
- Captured
- 2026-09-21T17:26:28.194Z
- SEC response SHA-256
de4123361405efcd0291343ed94db7c24d43e6c36dbcd4d45ba588f463c7f9d1
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001763950.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))